- Home
- OPTT vs CVKD Comparison
OPTT vs CVKD Comparison
Compare OPTT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- CVKD
- Stock Information
- Founded
- OPTT 1984
- CVKD 2022
- Country
- OPTT United States
- CVKD United States
- Employees
- OPTT N/A
- CVKD N/A
- Industry
- OPTT Electric Utilities: Central
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- OPTT Utilities
- CVKD Health Care
- Exchange
- OPTT Nasdaq
- CVKD Nasdaq
- Market Cap
- OPTT 89.7M
- CVKD 29.5M
- IPO Year
- OPTT 2007
- CVKD 2023
- Fundamental
- Price
- OPTT $0.52
- CVKD $12.80
- Analyst Decision
- OPTT
- CVKD Strong Buy
- Analyst Count
- OPTT 0
- CVKD 1
- Target Price
- OPTT N/A
- CVKD $32.00
- AVG Volume (30 Days)
- OPTT 3.7M
- CVKD 32.3K
- Earning Date
- OPTT 07-24-2025
- CVKD 08-06-2025
- Dividend Yield
- OPTT N/A
- CVKD N/A
- EPS Growth
- OPTT N/A
- CVKD N/A
- EPS
- OPTT N/A
- CVKD N/A
- Revenue
- OPTT $6,117,000.00
- CVKD N/A
- Revenue This Year
- OPTT N/A
- CVKD N/A
- Revenue Next Year
- OPTT N/A
- CVKD N/A
- P/E Ratio
- OPTT N/A
- CVKD N/A
- Revenue Growth
- OPTT 24.00
- CVKD N/A
- 52 Week Low
- OPTT $0.14
- CVKD $5.70
- 52 Week High
- OPTT $1.75
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- OPTT 50.72
- CVKD 49.60
- Support Level
- OPTT $0.45
- CVKD $11.00
- Resistance Level
- OPTT $0.53
- CVKD $13.71
- Average True Range (ATR)
- OPTT 0.04
- CVKD 1.14
- MACD
- OPTT -0.00
- CVKD 0.10
- Stochastic Oscillator
- OPTT 46.15
- CVKD 63.54
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.